Insertion of Myc into Igh Accelerates Peritoneal Plasmacytomas in Mice
Published version of a preprint
Abstract
Gene-targeted mice that contain a His6-tagged mouse c-Myc cDNA, MycHis, inserted head to head into different sites of the mouse immunoglobulin heavy-chain locus, Igh, mimic the chromosomal T(12;15)(Igh-Myc) translocation that results in the activation of Myc in the great majority of mouse plasmacytomas. Mice carrying MycHis just 5′ of the intronic heavy-chain enhancer Eμ (strain iMycEμ) provide a specific model of the type of T(12;15) found in a subset (∼20%) of plasmacytomas that develop “spontaneously” in the gut-associated lymphoid tissue (GALT) of interleukin-6 transgenic BALB/c (C) mice. Here we show that the transfer of the iMycEμ transgene from a mixed genetic background of segregating C57BL/6 × 129/SvJ alleles to the background of C increased the incidence of GALT plasmacytomas by a factor of 2.5 in first-generation backcross mice (C.iMycEμ N1). Third-generation backcross mice (C.iMycEμ N3, ∼94% C alleles) were hypersusceptible to inflammation-induced peritoneal plasmacytomas (tumor incidence, 100%; mean tumor onset, 86 ± 28 days) compared with inbred C mice (tumor incidence, 5% on day 150 after tumor induction). Peritoneal plasmacytomas of C.iMycEμ N3 mice overexpressed MycHis, produced monoclonal immunoglobulin, and exhibited a unique plasma cell signature upon gene expression profiling on mouse Lymphochip cDNA microarrays. These findings indicated that the iMycEμ transgene accelerates plasmacytoma development by collaborating with tumor susceptibility alleles of strain C and circumventing the requirement for tumor precursors to acquire deregulated Myc by chromosomal translocation.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Although there was no increase in spontaneous tumour formation in MDMX3SA animals, these mice were more prone to Myc-induced tumorigenesis.
“Surprisingly, although there was no increase in spontaneous tumour formation in MDMX3SA animals, these mice were more prone to Myc-induced tumorigenesis69 (discussed below).”
From MDM2, MDMX and p53 in oncogenesis and cancer therapy (2013) · cites this paper as [69]
Cites
The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
Adams, J. M., Harris, A. W., Pinkert, C. A., Corcoran, L. M., Alexander, W. S., Cory, S., Palmiter, R. D., & Brinster, R. L. (1985) · Nature · doi:10.1038/318533a0 · Cited by 1,778 · see citing works
Plasma cell differentiation requires the transcription factor XBP-1
Reimold, A., Iwakoshi, N., Manis, J., Vallabhajosyula, P., Szomolanyi-Tsuda, E., Gravallese, E., Friend, D., Grusby, M., Alt, F., & Glimcher, L. (2001) · Nature · doi:10.1038/35085509 · Cited by 1,371 · see citing works
Shaffer, A. L., Shelef, M. A., Iwakoshi, N. N., Lee, A., Qian, S., Zhao, H., Yu, X., Yang, L., Tan, B. K., Rosenwald, A., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.06.010 · Cited by 1,060 · see citing works
Self-citationShaffer, A. L., Lin, K., Kuo, T. C., Yu, X., Hurt, E. M., Rosenwald, A., Giltnane, J. M., Yang, L., Zhao, H., Calame, K. L., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00335-7 · Cited by 1,048 · see citing works
Self-citationReversible tumorigenesis by MYC in hematopoietic lineages.
Felsher, D., & Bishop, J. (1999) · Molecules and Cells · doi:10.1016/s1097-2765(00)80367-6 · Cited by 917 · see citing works
Shaffer, A. L., Yu, X., He, Y., Boldrick, J. C., Chan, E. P., & Staudt, L. M. (2000) · Immunity · doi:10.1016/s1074-7613(00)00020-0 · Cited by 879 · see citing works
Self-citationRegulation of B-cell fate by antigen-receptor signals
Niiro, H., & Clark, E. A. (2002) · Nature reviews. Immunology · doi:10.1038/nri955 · Cited by 626 · see citing works
Proteasome inhibitors disrupt the unfolded protein response in myeloma cells
Lee, A., Iwakoshi, N. N., Anderson, K. C., & Glimcher, L. H. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1334037100 · Cited by 600 · see citing works
c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progressionPreprint
Baudino, T. A., McKay, C., Pendeville, H., Nilsson, J. A., Maclean, K. H., White, E. L., Davis, A. C., Ihle, J. N., & Cleveland, J. L. (2002) · Genes & Development · doi:10.1101/gad.1024602 · Cited by 516 · see citing works
Myc pathways provoking cell suicide and cancer
Nilsson, J. A., & Cleveland, J. L. (2003) · Oncogene · doi:10.1038/sj.onc.1207261 · Cited by 462 · see citing works
Novel myc oncogene RNA from abortive immunoglobulin-gene recombination in mouse plasmacytomas
Shen-Ong, G. L. C., Keath, E. J., Piccoli, S. P., & Cole, M. D. (1982) · Cell · doi:10.1016/0092-8674(82)90137-4 · Cited by 454 · see citing works
Repression of c- myc Transcription by Blimp-1, an Inducer of Terminal B Cell Differentiation
Lin, Y., Wong, K., & Calame, K. L. (1997) · Science · doi:10.1126/science.276.5312.596 · Cited by 429 · see citing works
Bethesda proposals for classification of lymphoid neoplasms in mice
Morse, H. C. (2002) · Blood · doi:10.1182/blood.v100.1.246 · Cited by 345 · see citing works
Signatures of the Immune Response
Shaffer, A. L., Rosenwald, A., Hurt, E. M., Giltnane, J. M., Lam, L. T., Pickeral, O. K., & Staudt, L. M. (2001) · Immunity · doi:10.1016/s1074-7613(01)00194-7 · Cited by 315 · see citing works
Self-citationHinson, R. M., Williams, J. A., & Shacter, E. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4885 · Cited by 305 · see citing works
A site–directed chromosomal translocation induced in embryonic stem cells by Cre-loxP recombination
Smith, A. J. H., Sousa, M. A. D., Kwabi‐Addo, B., Heppell-Parton, A. C., Impey, H. L., & Rabbitts, P. H. (1995) · Nature Genetics · doi:10.1038/ng0495-376 · Cited by 254 · see citing works
Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Sabet, H., TRAN, T., Powell, J. I., Yang, L., MARTI, G. E., Moore, D., et al. (1999) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1999.64.71 · Cited by 247 · see citing works
Self-citationTarte, K., Zhan, F., Vos, J. D., Klein, B., & Shaughnessy, J. D. (2003) · Blood · doi:10.1182/blood-2002-10-3161 · Cited by 215 · see citing works
Kovalchuk, A. L., Qi, C., Torrey, T. A., Taddesse-Heath, L., Feigenbaum, L., Park, S. S., Gerbitz, A., Klobeck, G., Hoertnagel, K., Polack, A., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.8.1183 · Cited by 204 · see citing works
Self-citationInduction of Plasma Cell Tumours in BALB/c Mice with 2,6,10,14-Tetramethylpentadecane (Pristane)
ANDERSON, P. N., & Potter, M. (1969) · Nature · doi:10.1038/222994a0 · Cited by 192 · see citing works
Self-citationLymphoma‐ and leukemia‐associated chromosomal translocations in healthy individuals
Janz, S., Potter, M., & Rabkin, C. S. (2003) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.10178 · Cited by 149 · see citing works
Self-citationZhang, S., Ramsay, E. S., & Mock, B. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2429 · Cited by 147 · see citing works
IL-6 transgenic mouse model for extraosseous plasmacytoma
Kovalchuk, A., Kim, J.-S., Park, S. S., Coleman, A., Ward, J., Morse, H., Kishimoto, T., Potter, M., & Janz, S. (2002) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.022643999 · Cited by 127 · see citing works
Self-citationReconstructing MYC: Figure 1.Preprint
Levens, D. (2003) · Genes & Development · doi:10.1101/gad.1095203 · Cited by 125 · see citing works
Neoplastic development in plasma cells
Potter, M. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00061.x · Cited by 124 · see citing works
Self-citationSuda, Y., Aizawa, S., Hirai, S.-I., Inoue, T., Furuta, Y., Suzuki, M., Hirohashi, S., & Ikawa, Y. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02751.x · Cited by 123 · see citing works
Schmidt, E. V., Pattengale, P. K., Weir, L., & Leder, P. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.16.6047 · Cited by 116 · see citing works
Insertion of c- Myc into Igh Induces B-Cell and Plasma-Cell Neoplasms in Mice
Park, S. S., Kim, J. S., Tessarollo, L., Owens, J. D., Peng, L., Han, S. S., Chung, S. T., Torrey, T. A., Cheung, W. C., Polakiewicz, R. D., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-0268 · Cited by 112 · see citing works
Self-citationDefective development of pristane-oil-induced plasmacytomas in interleukin-6-deficient BALB/c mice.
(1997) · Europe PMC (PubMed Central) · Cited by 111 · see citing works
Histology of Developing Plasma Cell Neoplasia Induced By Mineral Oil in BALB/c Mice
Potter, M. J., & MacCardle, R. C. (1964) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/33.3.497 · Cited by 96 · see citing works
Self-citationTahara, M., Pergolizzi, R. G., Kobayashi, H., Krause, A., Luettich, K., LESSER, M. L., & Crystal, R. G. (2004) · Nature Medicine · doi:10.1038/nm1086 · Cited by 86 · see citing works
Shacter, E., Arzadon, G., & Williams, J. A. (1992) · Blood · doi:10.1182/blood.v80.1.194.bloodjournal801194 · Cited by 86 · see citing works
An E mu‐v‐abl transgene elicits plasmacytomas in concert with an activated myc gene.
Rosenbaum, H., Harris, A. W., Bath, M. L., McNeall, J., Webb, E., Adams, J. M., & Cory, S. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08187.x · Cited by 84 · see citing works
Efficiency Alleles of the Pctr1 Modifier Locus for Plasmacytoma Susceptibility
Zhang, S.-L., Dubois, W., Ramsay, E. S., Bliskovski, V., Morse, H. C., Taddesse-Heath, L., Vass, W. C., DePinho, R. A., & Mock, B. A. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.1.310-318.2001 · Cited by 83 · see citing works
Self-citationPotter, M., Mushinski, E. B., Wax, J. S., Hartley, J. W., & Mock, B. A. (1994) · PubMed · Cited by 82 · see citing works
Self-citationPeritoneal Plasmacytomagenesis in Mice: Comparison of Different Pristane Dose Regimens 2
Potter, M. J., & Wax, J. S. (1983) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/71.2.391 · Cited by 71 · see citing works
Self-citationAvian v- myc Replaces Chromosomal Translocation in Murine Plasmacytomagenesis
Potter, M., Mushinski, J. F., Mushinski, E. B., Brust, S., Wax, J. S., Wiener, F., Babonits, M., Rapp, U. R., & Morse, H. C. (1987) · Science · doi:10.1126/science.3810165 · Cited by 64 · see citing works
Self-citationSpecific pathogen-free BALB/cAn mice are refractory to plasmacytoma induction by pristane
Byrd, L. G., McDonald, A. H., Gold, L., & Potter, M. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.10.3632 · Cited by 62 · see citing works
Self-citationPotter, M. J., Pumphrey, J. G., & Bailey, D. W. (1975) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/54.6.1413 · Cited by 60 · see citing works
Self-citationTFIIH Operates through an Expanded Proximal Promoter To Fine-Tune c -myc Expression
Weber, A., Liu, J., Collins, I. J., & Levens, D. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.25.1.147-161.2005 · Cited by 60 · see citing works
Janz, S., Müller, J. R., Shaughnessy, J. D., & Potter, M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.15.7361 · Cited by 59 · see citing works
Self-citationProlonged adjuvant stimulation in germ-free BALB-c mice: development of plasma cell neoplasia.
McIntire, K. R., & Princler, G. L. (1969) · PubMed · Cited by 56 · see citing works
Clynes, R., Wax, J., Stanton, L. W., Smith‐Gill, S. J., Potter, M., & Marcu, K. B. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.16.6067 · Cited by 43 · see citing works
Self-citationBliskovsky, V. V., Ramsay, E. S., Scott, J., Dubois, W., Shi, W., Zhang, S., Qian, X., Lowy, D. R., & Mock, B. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2431627100 · Cited by 33 · see citing works
Self-citationSilva, S., Kovalchuk, A. L., Kim, J. S., Klein, G., & Janz, S. (2003) · PubMed · Cited by 32 · see citing works
Self-citationA retrovirus that expresses v-abl and c-myc oncogenes rapidly induces plasmacytomas.
Largaespada, D. A., Kaehler, D. A., Mishak, H., Weissinger, E. M., Potter, M., Mushinski, J. F., & Risser, R. (1992) · PubMed · Cited by 32 · see citing works
Self-citationPalomo, C., Zou, X., Nicholson, I., Bützler, C., & Brüggemann, M. (1999) · PubMed · Cited by 30 · see citing works
Troppmair, J., Potter, M., Wax, J. S., & Rapp, U. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.24.9941 · Cited by 29 · see citing works
Self-citationRapid induction of B-cell lymphomas in mice carrying a human IgH/c-mycYAC
Bützler, C., Zou, X., Popov, A. V., & Brüggemann, M. (1997) · Oncogene · doi:10.1038/sj.onc.1200968 · Cited by 27 · see citing works
The Effect of the nude Gene on Plasmacytoma Development in BALB/cAn Mice
Byrd, L. G., Potter, M., Mock, B. A., & Huppi, K. E. (1988) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-50059-6_41 · Cited by 4 · see citing works
Self-citationRonai, Z. A., Polotskaya, A., Gradia, S., Amin, S. G., & Hecht, S. S. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960703)67:1 · Cited by 2 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
MDM2, MDMX and p53 in oncogenesis and cancer therapy
Wade, M., Li, Y.-C., & Wahl, G. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3430 · Cited by 1,279 · see citing works
Case, A. J., McGill, J. L., Tygrett, L. T., Shirasawa, T., Spitz, D. R., Waldschmidt, T. J., Legge, K. L., & Domann, F. E. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.11.025 · Cited by 107 · see citing works
Myc translocations in B cell and plasma cell neoplasms
Janz, S. (2006) · DNA repair · doi:10.1016/j.dnarep.2006.05.017 · Cited by 101 · see citing works
Self-citationPreclinical validation of interleukin 6 as a therapeutic target in multiple myeloma
Rosean, T. R., Tompkins, V., Tricot, G., Holman, C. J., Olivier, A., Zhan, F., & Janz, S. (2014) · Immunologic research · doi:10.1007/s12026-014-8528-x · Cited by 59 · see citing works
Self-citationG-Rich Proto-Oncogenes Are Targeted for Genomic Instability in B-Cell Lymphomas
Duquette, M. L., Huber, M. D., & Maizels, N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2419 · Cited by 66 · see citing works
Truffinet, V., Pinaud, E., Cogné, N., Petit, B., Guglielmi, L., Cogné, M., & Denizot, Y. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.9.6033 · Cited by 62 · see citing works
The feed-forward loop between YB-1 and MYC is essential for multiple myeloma cell survival
Bommert, K., Effenberger, M., Leich, E., Küspert, M., Murphy, D. J., Langer, C., Moll, R., Janz, S., Mottok, A., Weißbach, S., et al. (2012) · Leukemia · doi:10.1038/leu.2012.185 · Cited by 62 · see citing works
Self-citationIL-6 and MYC collaborate in plasma cell tumor formation in mice.
Rutsch, S., Neppalli, V., Shin, D.-M., Dubois, W. D., Morse, H., Goldschmidt, H., & Janz, S. (2010) · Blood · doi:10.1182/blood-2009-08-237941 · Cited by 58 · see citing works
Self-citationThe tumor microenvironment is the main source of IL-6 for plasma cell tumor development in mice
Rosean, T. R., Tompkins, V., Olivier, A., Sompallae, R., Norian, L., Morse, H. C., Waldschmidt, T., & Janz, S. (2014) · Leukemia · doi:10.1038/leu.2014.260 · Cited by 22 · see citing works
Self-citationHan, S., Peng, L., Chung, S.-T., Dubois, W., Maeng, S., Shaffer, A. L., Sporn, M. B., & Janz, S. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-22 · Cited by 15 · see citing works
Self-citationFiancette, R., Rouaud, P., Vincent‐Fabert, C., Laffleur, B., Magnone, V., Cogné, M., & Denizot, Y. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102059 · Cited by 14 · see citing works
The IgH 3’ regulatory region and c-myc-induced B-cell lymphomagenesis
Ghazzaui, N., Saintamand, A., Issaoui, H., Vincent‐Fabert, C., & Denizot, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.12535 · Cited by 14 · see citing works
Mouse Models of c-myc Deregulation Driven by IgH Locus Enhancers as Models of B-Cell Lymphomagenesis
Ferrad, M., Ghazzaui, N., Issaoui, H., Cook‐Moreau, J., & Denizot, Y. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01564 · Cited by 13 · see citing works
Plasma cell tumour progression in iMycEµ gene‐insertion mice
Kim, J., Han, S., Park, S. S., McNeil, N. E., & Janz, S. (2006) · The Journal of Pathology · doi:10.1002/path.1940 · Cited by 12 · see citing works
Self-citationEnhancing B-Cell Malignancies—On Repurposing Enhancer Activity towards Cancer
Kasprzyk, M. E., Sura, W., & Dzikiewicz‐Krawczyk, A. (2021) · Cancers · doi:10.3390/cancers13133270 · Cited by 11 · see citing works
Park, E. S., Shaughnessy, J. D., Gupta, S., Wang, H., Lee, J., Woo, H. G., Zhan, F., Owens, J. D., Potter, M., Janz, S., et al. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-302 · Cited by 11 · see citing works
Self-citationLeGrand, J., Park, E. S., Wang, H., Gupta, S., Owens, J. D., Nelson, P. J., Dubois, W., Bair, T., Janz, S., & Mushinski, J. F. (2011) · Blood · doi:10.1182/blood-2011-06-363887 · Cited by 7 · see citing works
Self-citationSaad, F., Saintamand, A., Rouaud, P., & Denizot, Y. (2014) · Oncoscience · doi:10.18632/oncoscience.81 · Cited by 7 · see citing works
Uncoupling between Ig somatic hypermutation and oncogene mutation in mouse lymphoma
Vincent‐Fabert, C., Truffinet, V., Fiancette, R., Petit, B., Cogné, N., Cogné, M., & Denizot, Y. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.10.011 · Cited by 6 · see citing works
Mouse Models of Human Blood Cancers
Li, S. (2008) · Springer eBooks · doi:10.1007/978-0-387-69132-9 · Cited by 6 · see citing works
Mouse Models of Human Mature B-Cell and Plasma Cell Neoplasms
Janz, S., Morse, H. C., & Teitell, M. A. (2008) · Springer eBooks · doi:10.1007/978-0-387-69132-9_8 · Cited by 6 · see citing works
Self-citationEfficient role of IgH 3′ regulatory region deficient B-cells in the development of oil granulomas
Ghazzaui, N., Saintamand, A., Issaoui, H., Saad, F., & Denizot, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.9588 · Cited by 3 · see citing works
The tumor microenvironment is critical for the development of plasma cell neoplasia in mice
Rosean, T. R., Janz, S., Waldschmidt, T. J., Goel, A., Colgan, J. D., & Bishop, G. A. (2014) · doi:10.17077/etd.4zfhrfac
Self-citationFiancette, R. (2011) · OpenGrey (Institut de l'Information Scientifique et Technique)
Market, E. (2025) · Digital Commons - RU (Rockefeller University) · doi:10.48496/g8j4-kf57
- Authors
- Park, S. S., Shaffer, A. L., Kim, J. S., duBois, W., Potter, M., Staudt, L. M., & Janz, S.
- Affiliations
- National Institutes of Health (US)
- 1Laboratory of Genetics and
- Venue
- Cancer Research
- Published
- 2005-09-01
- Volume
- 65
- Issue
- 17
- Pages
- 7644-7652
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2111338797
- Cited by
- 27
- References
- 51
- Citations by year
- 2025: 1 · 2021: 1 · 2020: 1 · 2016: 2 · 2014: 4 · 2013: 1 · 2012: 1
- FWCI
- 1.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Multiple Myeloma Research and Treatments
- Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment
- Health Sciences › Medicine › Genetics › Chronic Lymphocytic Leukemia Research
- Keywords
- c-Myc, immunoglobulin heavy chain locus, plasmacytoma, gene-targeted mice, backcross mice, gut-associated lymphoid tissue, M protein, gene expression profiling, MYC overexpression
- MeSH terms
- Alleles, Animals, Genes, Immunoglobulin, Lymphoid Tissue, Mice, Inbred BALB C, Mice, Transgenic, Peritoneal Neoplasms, Plasmacytoma, Precancerous Conditions, Gene Expression, Genes, myc, Transgenes, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
